Galmed Pharmaceuticals
GLMD
#9962
Rank
โ‚น0.35 B
Marketcap
โ‚น236.54
Share price
-5.41%
Change (1 day)
-45.51%
Change (1 year)

Revenue for Galmed Pharmaceuticals (GLMD)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Galmed Pharmaceuticals from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A-100%
2018 โ‚น0.14 B105.7%
2017 โ‚น69.27 M118.3%
2016 โ‚น31.73 M
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น370.10 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น169.93 BN/A๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น18.07 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.63 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA